Alkemist Labs again achieves ISO 17025:2017 accreditation, adds CBD & terpenes methods

The accreditation from the American Association for Laboratory Accreditation (A2LA) has been renewed until February 28th, 2022.

“Having the CBD method and the new terpenes method included in this most recent accreditation further solidifies our standing as a hemp testing authority,”​ stated Elan Sudberg, CEO of Alkemist Labs, in a press release. “And it’s important to note that the identification portion of the testing scope meets the A2LA P112 Flexible Scope Policy, confirming our ability to give accurate results without delay for some complicated material.”​

The accreditation process involved a thorough assessment and review of the lab’s quality management system and competence to perform Dietary Supplement Identification and Qualitative Analysis HPTLC testing and Botanical Identification and Qualitative Analysis by Microscopy. 

The accreditation means that Alkemist Labs meets technical and quality benchmarks as required by ISO/IEC 17025:2017. With the successful completion of the A2LA evaluation process, including an assessment of the laboratory's compliance with the A2LA Food Testing Program Requirements containing 2018 “AOAC Guidelines for Laboratories Performing Microbiological and Chemical Analyses of Food, Dietary Supplements, and Pharmaceuticals”​ accreditation is granted to Alkemist Labs to perform tests within their scope on dietary supplements, crude plant matter, plant extracts, oils, raw materials, finished products, fungal, algal species, and cannabis. 

“Alkemist Labs was one of the first cannabis testing laboratories accredited by A2LA back in 2015, demonstrating their dedication to quality testing in this evolving industry,”​ said Chris Gunning, A2LA General Manager of Accreditation Services.  “We are pleased to see them expanding their capabilities to greater serve the needs of the market in California.”​

The Alkemist Labs Accreditation Certificate #3851.01 may be viewed here.​